{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:39:25Z","timestamp":1786541965866,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sodium and potassium imbalances are pervasive in patients with neuroendocrine cancer (NEC), partly due to syndrome of inappropriate antidiuretic hormone secretion, which impact their prognosis. Whether urinary sodium and potassium excretion is associated with outcomes in patients with NEC remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of 759 patients diagnosed with NEC enrolled in a UK biobank cohort range from 2000 to 2020. Cox proportional hazards models was used to examine the associations between urinary sodium and potassium excretion. Interaction and stratified analyses were conducted including gender, age, NEC primary site, hypertension and sodium intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 759 NEC patients, 54.81% were male and 45.19% were female, with a mean age of 52.69\u00a0\u00b1\u00a06.11 years. During a median follow-up period of 14.0 months, there were 586 overall deaths and 549 cancer-specific deaths. After adjusting for confounding factors, the urinary sodium-to-potassium ratio (STP) was significantly associated with both overall mortality (HR\u00a0=\u00a01.16, 95% CI: 1.05-1.28) and cancer-specific mortality (HR\u00a0=\u00a01.16, 95% CI: 1.05-1.28). When comparing the higher STP group (\u22651.29) with the lower STP group (&amp;lt;1.29), the HR was 1.26 (95% CI: 1.04\u20131.52) for overall mortality and 1.26 (95% CI: 1.04\u20131.53) for cancer-specific mortality after full adjustment. Additional sensitivity analyses restricted to pulmonary NEC and stratified by primary tumor site showed directionally consistent results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher urinary sodium and lower potassium excretion, as measured by the STP ratio, were associated with increased risks of both overall mortality and cancer-specific mortality in patients with NEC. Our findings suggest that the STP ratio, a parsimonious clinic-ready marker, could provide incremental prognostic information for NEC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1866503","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:11:10Z","timestamp":1786540270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of urinary sodium and potassium excretion with outcomes of neuroendocrine cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Qichao","family":"Sun","sequence":"first","affiliation":[{"name":"Cancer Institute, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayire","family":"Aji","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine, The Sixth Affiliated Hospital of Xinjiang Medical University","place":["Urumqi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[{"name":"Pathology Department, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengrui","family":"Nan","sequence":"additional","affiliation":[{"name":"Cancer Institute, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Institute, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]},{"name":"International Center of Future Science, Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Institute, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]},{"name":"Cancer Center, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00428-011-1060-7","article-title":"The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers","volume":"458","author":"Volante","year":"2011","journal-title":"Virchows Arch"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0445-0","article-title":"Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data","volume":"451","author":"Righi","year":"2007","journal-title":"Virchows Arch"},{"key":"B3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.49.8089","article-title":"Rare case of syndrome of inappropriate antidiuretic hormone as the initial presentation of ovarian cancer recurrence","volume":"33","author":"Murphy","year":"2015","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-024-00508-y","article-title":"Gastric neuroendocrine neoplasms","volume":"10","author":"Lamberti","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/annonc\/mdr431","article-title":"High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH)","volume":"22","author":"Kenz","year":"2011","journal-title":"Ann Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/cs20180194","article-title":"Electrolyte transport in the renal collecting duct and its regulation by the renin-angiotensin-aldosterone system","volume":"133","author":"Yamazaki","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/eo-22-0056","article-title":"Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer","volume":"2","author":"Donald","year":"2022","journal-title":"Endocr Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01431-7","article-title":"Sodium-to-potassium ratio and renal functional decline","volume":"47","author":"Tabara","year":"2024","journal-title":"Hypertens Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2015010022","article-title":"Urinary sodium and potassium excretion and CKD progression","volume":"27","author":"He","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1201\/9780203912997.sec8","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.118.023099","article-title":"Spot urine sodium-to-potassium ratio is a predictor of stroke","volume":"50","author":"Averill","year":"2019","journal-title":"Stroke"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0000000000000734","article-title":"Descriptive epidemiology of spot urine sodium-to-potassium ratio clarified close relationship with blood pressure level: the Nagahama study","volume":"33","author":"Tabara","year":"2015","journal-title":"J Hypertens"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2109794","article-title":"24-hour urinary sodium and potassium excretion and cardiovascular risk","volume":"386","author":"Ma","year":"2022","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.119.12726","article-title":"Urinary sodium excretion, blood pressure, and risk of future cardiovascular disease and mortality in subjects without prior cardiovascular disease","volume":"73","author":"Welsh","year":"2019","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2014.76","article-title":"Six random specimens of daytime casual urine on different days are sufficient to estimate daily sodium\/potassium ratio in comparison to 7-day 24-h urine collections","volume":"37","author":"Iwahori","year":"2014","journal-title":"Hypertens Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw287","article-title":"Estimating 24-h urinary sodium\/potassium ratio from casual ('spot') urinary sodium\/potassium ratio: the INTERSALT Study","volume":"46","author":"Iwahori","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: A systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1311989","article-title":"Association of urinary sodium and potassium excretion with blood pressure","volume":"371","author":"Mente","year":"2014","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/bs.acr.2022.03.005","article-title":"Nephrotoxicity in cancer treatment: An update","volume":"155","author":"Chen","year":"2022","journal-title":"Adv Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-023-08347-5","article-title":"The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal Malignant tumors","volume":"281","author":"Dang","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00280-017-3392-8","article-title":"Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management","volume":"80","author":"Oronsky","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00779","article-title":"Electrolyte disorders induced by antineoplastic drugs","volume":"10","author":"Verzicco","year":"2020","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3332\/ecancer.2012.279","article-title":"Syndrome of inappropriate anti-diuretic hormone in non-small cell lung carcinoma: a case report","volume":"6","author":"McDonald","year":"2012","journal-title":"Ecancermedicalscience"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77407","article-title":"Syndrome of inappropriate antidiuretic hormone (SIADH) in chronic respiratory diseases: A comprehensive review","volume":"17","author":"Al Zaman","year":"2025","journal-title":"Cureus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040898","article-title":"The interplay of dysregulated pH and electrolyte imbalance in cancer","volume":"12","author":"Alfarouk","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2016.1140753","article-title":"Tumor metabolism, cancer cell transporters, and microenvironmental resistance","volume":"31","author":"Alfarouk","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12722","article-title":"Estimation of daily sodium and potassium excretion using spot urine and 24-hour urine samples in a black population (Benin)","volume":"18","author":"Miz\u00e9houn-Adissoda","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-00879-3","article-title":"The spot urine sodium-to-potassium ratio as a marker of hypertension risk","volume":"45","author":"Tabara","year":"2022","journal-title":"Hypertens Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpt143","article-title":"Sodium reduction is a public health priority: reflections on the Institute of Medicine's report, sodium intake in populations: assessment of evidence","volume":"26","author":"Gunn","year":"2013","journal-title":"Am J Hypertens"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.99.12.1593","article-title":"Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans","volume":"99","author":"Orfanos","year":"1999","journal-title":"Circulation"},{"key":"B35","first-page":"49","article-title":"Diurnal electrolyte excretion pattern affects estimates of electrolyte status based on 24-hour, half-day, and overnight urine","volume":"37","author":"Pan","year":"1994","journal-title":"Chin J Physiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1866503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:11:12Z","timestamp":1786540272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1866503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":35,"alternative-id":["10.3389\/fonc.2026.1866503"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1866503","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1866503"}}